Dorothee Herlyn

Dorothee Herlyn

UNVERIFIED PROFILE

Are you Dorothee Herlyn?   Register this Author

Register author
Dorothee Herlyn

Dorothee Herlyn

Publications by authors named "Dorothee Herlyn"

Are you Dorothee Herlyn?   Register this Author

37Publications

630Reads

26Profile Views

Highlights of melanoma research presented at the 49th annual meeting of the American Society of Clinical Oncology in Chicago, 2013.

Pigment Cell Melanoma Res 2014 Jan 1;27(1):E1-5. Epub 2013 Nov 1.

Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12182DOI Listing
January 2014

Highlights of the 2012 Congress of the Society for Melanoma Research, 8-11 November 2012, Hollywood, CA.

Melanoma Res 2013 Jun;23(3):237-40

Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e3283610528DOI Listing
June 2013

Highlights of novel melanoma therapies presented at the 8th International Congress of the Society for Melanoma Research (SMR) Tampa, FL, November 9-11, 2011.

Authors:
Dorothee Herlyn

Cancer Immunol Immunother 2012 Jun 7;61(6):949-51. Epub 2012 Mar 7.

The Wistar Institute, Philadelphia, PA 19096, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-012-1228-2DOI Listing
June 2012

EpCAM-autoantibody levels in the course of disease of ovarian cancer patients.

Med Oncol 2011 Jun 10;28(2):626-30. Epub 2010 Apr 10.

Clinic of Obstetrics and Gynaecology, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-010-9486-3DOI Listing
June 2011

Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer.

Cancer Immunol Immunother 2009 Apr 17;58(4):475-92. Epub 2008 Oct 17.

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0598-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762732PMC
April 2009

Chemokines and the microenvironment in neuroectodermal tumor-host interaction.

Semin Cancer Biol 2009 Apr 13;19(2):92-6. Epub 2008 Nov 13.

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1044579X0800090
Publisher Site
http://dx.doi.org/10.1016/j.semcancer.2008.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806055PMC
April 2009

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.

Proc Natl Acad Sci U S A 2006 Nov 1;103(46):17361-5. Epub 2006 Nov 1.

Cancer Immunobiology Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, Dallas, TX 75390, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0608113103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838539PMC
November 2006

Preferential involvement of CX chemokine receptor 4 and CX chemokine ligand 12 in T-cell migration toward melanoma cells.

Cancer Biol Ther 2006 Oct 4;5(10):1304-12. Epub 2006 Oct 4.

The Wistar Institute, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, and Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.5.10.3153DOI Listing
October 2006

Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patients.

Cancer Immunol Immunother 2006 May 21;55(5):528-37. Epub 2005 Jul 21.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-005-0026-5DOI Listing
May 2006

CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.

J Transl Med 2005 Nov 10;3:41. Epub 2005 Nov 10.

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://translational-medicine.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1479-5876-3-41DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1308870PMC
November 2005

Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.

Clin Cancer Res 2005 Apr;11(8):2840-52

Department of Tumor Progression and Tumor Defense, German Cancer Research Center, University of Heidelberg, Heidelberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-04-1935DOI Listing
April 2005

Colon cancer antigen and anti-idiotype vaccines.

Cancer Chemother Biol Response Modif 2003 ;21:287-98

The Wistar Institute, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
September 2004

Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.

Clin Cancer Res 2003 Oct;9(13):4782-91

Department of Obstetrics, Gynecology and Reproductive Biology, Division of Gynecologic Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
October 2003

Immunization procedures for anti-idiotypic antibody induction in mice and rats.

J Immunol Methods 2002 Jun;264(1-2):121-33

The Wistar Institute, 3601 Spruce Street, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(02)00091-1DOI Listing
June 2002